Results 11 to 20 of about 836,270 (361)

Tumor cell-derived microparticles: a new form of cancer vaccine. [PDF]

open access: yesOncoimmunology, 2015
For cancer vaccines, tumor antigen availability is currently not an issue due to technical advances. However, the generation of optimal immune stimulation during vaccination is challenging.
Zhang H, Huang B.
europepmc   +5 more sources

Mesenchymal stem cell-derived microparticles: a promising therapeutic strategy. [PDF]

open access: yesInt J Mol Sci, 2014
Mesenchymal stem cells (MSCs) are multipotent stem cells that give rise to various cell types of the mesodermal germ layer. Because of their unique ability to home in on injured and cancerous tissues, MSCs are of great potential in regenerative medicine.
Tan X, Gong YZ, Wu P, Liao DF, Zheng XL.
europepmc   +6 more sources

A flow cytometric method for characterization of circulating cell-derived microparticles in plasma. [PDF]

open access: yesJ Extracell Vesicles, 2014
Background and aim Previous studies on circulating microparticles (MPs) indicate that the majority of MPs are of a size below the detection limit of most standard flow cytometers. The objective of the present study was to establish a method to analyze MP
Nielsen MH   +3 more
europepmc   +9 more sources

Delivery of chemotherapeutic drugs in tumour cell-derived microparticles [PDF]

open access: bronzeNature Communications, 2012
Cellular microparticles are vesicular plasma membrane fragments with a diameter of 100-1,000 nanometres that are shed by cells in response to various physiological and artificial stimuli. Here we demonstrate that tumour cell-derived microparticles can be used as vectors to deliver chemotherapeutic drugs.
Ke Tang   +13 more
semanticscholar   +4 more sources

Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation? [PDF]

open access: goldJ Cell Mol Med, 2012
AbstractIntroductionMicroparticle formation, structure and compositionMicroparticle isolation, preparation and measurementMicroparticles as markers of cardiovascular diseasesMicroparticles as actors in cardiovascular diseasesPharmacological modulation of plasma MP concentrationsConclusionCardiovascular diseases remain an important cause of morbi ...
Baron M   +3 more
europepmc   +9 more sources

Pleomorphic Structures in Human Blood Are Red Blood Cell-Derived Microparticles, Not Bacteria. [PDF]

open access: yesPLoS One, 2016
Background Red blood cell (RBC) transfusions are a common, life-saving therapy for many patients, but they have also been associated with poor clinical outcomes.
Mitchell AJ   +10 more
europepmc   +2 more sources

Freeze-Derived Anisotropic Porous Microparticles for Engineered Mesenchymal Stem Cell Loading and Wound Healing [PDF]

open access: yesResearch
Hydrogel microparticles that can effectively deliver mesenchymal stem cells (MSCs) are expected to accelerate wound repair progress. Attempts in the area are focusing on improving the functions of the microparticles and MSCs to promote the therapeutic ...
Rongwei Cai   +4 more
doaj   +2 more sources

Platelet-, leucocyte- and red cell-derived microparticles in stored whole blood, with and without leucofiltration, with and without ionising radiation. [PDF]

open access: yesBlood Transfus, 2018
BACKGROUND Storage lesion, including microparticle formation, has been partially characterised in whole blood, but not in all combinations of pre-storage leucofiltration and/or irradiation.
Saito S   +4 more
europepmc   +2 more sources

Glycoxidated ferritin induces the release of microparticles positive for Toll-like receptors derived from peripheral blood CD14+ cells [PDF]

open access: diamondArchives of Biological Sciences, 2017
Both increased serum ferritin levels and Toll-like receptor (TLR) activation show independent association with the inflammatory processes. During inflammation, cell activation and apoptosis are accompanied by the release of membrane-derived ...
López-Soto Luis Fernando   +9 more
doaj   +3 more sources

Home - About - Disclaimer - Privacy